Skip to Main Content

The ALS Association Central & Southern Ohio Chapter


Latest News

Whole Exome Sequencing Reveals New ALS Gene
Read More


New Disease Model Highlights Astrocyte Contribution to ALS
Read More


The 2014 ALS Association Clinical Conference
Read More


In a joint statement to the ALS community, The ALS Association and several of its partner organizations involved in the fight against ALS have presented their stance on broad access to ALS therapeutics in the early stages of development. This includes access to Genervon’s GM604 (GM6) drug for people living with the disease.

 The Association’s website contains this statement.

ALS Quick Links

Veterans with ALS Icon

Care Services Icon

ALS Registry Icon

Upcoming Events Icon

Walk to Defeat ALS Icon

Ways to Support Icon

Join the Conversation

Facebook Icon Twitter Icon YouTube Icon LinkedIn Icon Instagram Icon

Facebook | Twitter | YouTube | LinkedIn | Instagram 


Please click HERE to fill out the
Volunteer Survey
and start volunteering today!

Volunteers- Phi Delts




Icon Facebook Icon Twitter Icon Youtube
    Icon Secondlife Icon Linkedin

OUR MISSION: Leading the fight to treat and cure ALS through global research and nationwide advocacy while also empowering people with Lou Gehrig's Disease and their families to live fuller lives by providing them with compassionate care and support.


The ALS Association Central & Southern Ohio Chapter
1170 Old Henderson Road, Suite 221, Columbus, Ohio  43220
866-273-2572 (toll free) - 614-273-2573 (fax) - (email)

All content and works posted on this website are owned and copyrighted by The ALS Association. © 2015
Lou Gehrig® used with permission of the Rip Van Winkle Foundation /